|1.||Menapace, Rupert: 4 articles (02/2008 - 04/2003)|
|2.||Rainer, Georg: 3 articles (02/2008 - 09/2003)|
|3.||Kiss, Barbara: 3 articles (10/2005 - 04/2003)|
|4.||Findl, Oliver: 3 articles (10/2005 - 04/2003)|
|5.||Theoharides, T C: 2 articles (12/2008 - 01/2005)|
|6.||Sant, G R: 2 articles (12/2008 - 01/2005)|
|7.||Amano, Shiro: 2 articles (11/2005 - 09/2002)|
|8.||Miyata, Kazunori: 2 articles (11/2005 - 09/2002)|
|9.||Sacu, Stefan: 2 articles (10/2005 - 09/2003)|
|10.||Petternel, Vanessa: 2 articles (09/2003 - 04/2003)|
09/01/2014 - "At day 15 after cataract surgery the postoperative endothelial cell count was 2102.9 ± 182.8 SD cells/mm(2) in Viscoat group and 2032.6 ± 160.4 SD cells/mm(2) in the VisThesia group (p > 0.1). "
01/01/2009 - "Viscoat is a nonpyrogenic, sterile, viscoelastic solution used to protect the endothelium and enhance visualization during cataract and corneal surgery. "
02/01/2008 - "Therefore, if Viscoat is used during cataract surgery, an additional cohesive OVD should be used for IOL implantation."
02/01/2008 - "Each patient's eyes were randomly assigned to receive Viscoat or DuoVisc during cataract surgery. "
02/01/2008 - "Comparison of the effect of Viscoat and DuoVisc on postoperative intraocular pressure after small-incision cataract surgery."
|2.||Corneal Endothelial Cell Loss
11/01/2004 - "To compare the influence of low-molecular-weight viscoelastics on postoperative intraocular pressure (IOP) and corneal endothelial cell loss after phacoemulsification Sixty-nine eyes undergoing phacoemulsification surgery were randomized to have either Opegan (Santen Pharmaceuticals, Osaka, Japan) alone or the soft-shell technique using Viscoat (Alcon Surgical, Fort Worth, TX) during phacoemulsification. "
02/01/2008 - "To compare the efficacy of the dispersive-viscoadaptive soft-shell technique using Viscoat and Healon 5 to the dispersive-cohesive soft-shell technique in reducing corneal endothelial cell damage during cataract surgery. "
11/01/2004 - "To evaluate whether the soft-shell technique using Viscoat (sodium hyaluronate 3%-chondroitin sulfate 4%) and Hyal-2000 (sodium hyaluronate 1%) reduces corneal endothelial cell damage during cataract surgery. "
01/01/2012 - "Improved intraoperative fundus visualization in corneal edema: the Viscoat trick."
04/01/2003 - "During phacoemulsification in a nonselected patient population, there was no difference in acute postoperative corneal edema and endothelial cell morphology after 3 months between a Viscoat and BSS Plus combination and an Ocucoat and Ringer's solution combination. "
|4.||Interstitial Cystitis (Interstitial Cystitis, Chronic)
09/01/2005 - "Comparison of the effectiveness of mitomycin-C and Viscoat on delayed adjustable strabismus surgery in rabbits."
09/01/2005 - "To determine a way to prevent the formation of adhesions and delay the time of suture adjustment in the course of adjustable strabismus surgery, an animal study was performed to assess and compare the effects of mitomycin C (Mit-C) and viscoelastic material Viscoat (sodium hyaluronate 3% and chondroitin sulphate 4%, Alcon, Fort Worth, TX). "
|1.||Hyaluronic Acid (Hyaluronan)
|4.||Chondroitin Sulfates (Chondroitin Sulfate)
|9.||1 Fuchs' endothelial Corneal dystrophy
|10.||1 posterior polar Cataract